Skip to main content

Table 4 Analysis of clinicopathologic factors associated with resolution of LDL-cholesterol at 6 month

From: Changes of lipid profiles after radical gastrectomy in patients with gastric cancer

  Abnormal → Abnormal (n = 45) Abnormal → Normal (n = 48) OR (95% CI) pvalue Adjust OR (95% CI) pvalue
Sex       
  Male 21(46.67) 34(70.83) 1   1  
  Female 24(53.33) 14(29.17) 0.36(0.153–0.847) 0.0192 0.39(0.16–0.95) 0.0369
Age (years)       
  Mean(SD) 58.71(8.56) 57.85(11.28) 1    
  Median(range) 61.00(38.00–73.00) 58.00(36.00–81.00) 0.99(0.95–1.03) 0.6786   
Stage       
  IA 37(82.22) 23(47.92) 1    
  IB 2(4.44) 5(10.42) 4.02(0.72–22.47) 0.9480   
  IIA 1(2.22) 3(6.25) 4.83(0.47–49.22) 0.9534   
  IIB 2(4.44) 6(12.5) 4.83(0.90–25.97) 0.9534   
  IIIA 1(2.22) 3(6.25) 4.83(0.47–49.22) 0.9534   
  IIIB   5(10.42) Inf 0.9148   
  IIIC   2(4.17) Inf 0.9435   
Comorbidity       
  No 23(51.11) 19(39.58) 1    
  Yes 22(48.89) 29(60.42) 1.60(0.70–3.63) 0.2654   
DM       
  No 42(93.33) 39(81.25) 1    
  Yes 3(6.67) 9(18.75) 3.23(0.82–12.81) 0.0952   
HBP       
  No 35(77.78) 36(75) 1    
  Yes 10(22.22) 12(25) 1.17(0.45–3.05) 0.7529   
Op approach       
  Open 35(77.78) 40(83.33) 1    
  Laparoscopic 10(22.22) 8(16.67) 0.70(0.25–1.97) 0.4992   
Resection extent       
  Total 8(17.78) 19(39.58) 1   1  
  Subtotal 37(82.22) 29(60.42) 0.33(0.13–0.86) 0.0234 0.36(0.14–0.97) 0.0438
Reconstruction       
  B-I 8(17.78) 4(8.33) 1   1  
  B-II 29(64.44) 22(45.83) 1.52(0.41–5.69) 0.3491 1.38(0.36–5.32) 0.3663
  RY 8(17.78) 22(45.83) 5.50 (1.29–23.39) 0.0050 4.47(1.01–19.68) 0.0143
  1. Statistics were carried out using univariate and multivariable logistic regression. Use of univariate analyses to select variables for multivariable models (P <0.05). B-I, Billorth I; B-II, Billroth II; RY, Roux en Y.